Related references
Note: Only part of the references are listed.Cyp46-mediated cholesterol loss promotes survival in stressed hippocampal neurons
Mauricio G. Martin et al.
NEUROBIOLOGY OF AGING (2011)
Cholesterol in Alzheimer's Disease: Unresolved Questions
Massimo Stefani et al.
CURRENT ALZHEIMER RESEARCH (2009)
Diminished hippocalcin expression in Huntington's disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons
Nikita Rudinskiy et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Mitochondrial Cholesterol Loading Exacerbates Amyloid β Peptide-Induced Inflammation and Neurotoxicity
Anna Fernandez et al.
JOURNAL OF NEUROSCIENCE (2009)
Specific Loss of Brain ABCA1 Increases Brain Cholesterol Uptake and Influences Neuronal Structure and Function
Joanna M. Karasinska et al.
JOURNAL OF NEUROSCIENCE (2009)
Molecular Consequences of Altered Neuronal Cholesterol Biosynthesis
Zeljka Korade et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Reduction of cholesterol synthesis in the mouse brain does not affect amyloid formation in Alzheimer's disease, but does extend lifespan
Rebekkah W. Halford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntingtons disease
Valerio Leoni et al.
BRAIN (2008)
Biological and Potential Therapeutic Roles of Sirtuin Deacetylases
D. M. Taylor et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease
Judit Pallos et al.
HUMAN MOLECULAR GENETICS (2008)
Statins reduce neuronal α-synuclein aggregation in in vitro models of Parkinson's disease
Pazit Bar-On et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Huntingtin Modulates Transcription, Occupies Gene Promoters In Vivo, and Binds Directly to DNA in a Polyglutamine-Dependent Manner
Caroline L. Benn et al.
JOURNAL OF NEUROSCIENCE (2008)
Dysregulation of gene expression in primary neuron models of Huntington's disease shows that polyglutamine-related effects on the striatal transcriptome may not be dependent on brain circuitry
Heike Runne et al.
JOURNAL OF NEUROSCIENCE (2008)
The effect of 24S-hydroxycholesterol on cholesterol homeostasis in neurons:: Quantitative changes to the cortical neuron proteome
Yuqin Wang et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Drug targeting of dysregulated transcription in Huntington's disease
Aleksey G. Kazantsev et al.
PROGRESS IN NEUROBIOLOGY (2007)
Progressive dysfunction of the cholesterol biosynthesis pathway in the R6/2 mouse model of Huntington's disease
Marta Valenza et al.
NEUROBIOLOGY OF DISEASE (2007)
Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation
Marta Valenza et al.
HUMAN MOLECULAR GENETICS (2007)
Interphase Nucleo-Cytoplasmic Shuttling and Localization of SIRT2 during Mitosis
Brian J. North et al.
PLOS ONE (2007)
SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction
Fei Wang et al.
AGING CELL (2007)
SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation
Enxuan Jing et al.
CELL METABOLISM (2007)
Sirtuin 2 inhibitors rescue α-synuclein-mediated toxicity in models of Parkinson's disease
Tiago Fleming Outeiro et al.
SCIENCE (2007)
Proteolipid protein is required for transport of sirtuin 2 into CNS myelin
Hauke B. Werner et al.
JOURNAL OF NEUROSCIENCE (2007)
Huntingtin interacting proteins are genetic modifiers of neurodegeneration
Linda S. Kaltenbach et al.
PLOS GENETICS (2007)
Brain neutral lipids mass is increased in α-synuclein gene-ablated mice
Gwendolyn Barcelo-Coblijn et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation
Jim P. Dompierre et al.
JOURNAL OF NEUROSCIENCE (2007)
Sirtuin 2, a mammalian homolog of yeast silent information regulator-2 longevity regulator, is an oligodendroglial protein that decelerates cell differentiation through deacetylating α-tubulin
Wenbo Li et al.
JOURNAL OF NEUROSCIENCE (2007)
Microtubule deacetylases, SirT2 and HDAC6, in the nervous system
Cherie M. Southwood et al.
NEUROCHEMICAL RESEARCH (2007)
Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo
Eugenia Trushina et al.
HUMAN MOLECULAR GENETICS (2006)
SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis
Alejandro Vaquero et al.
GENES & DEVELOPMENT (2006)
HDAC6 and microtubules are required for autophagic degradation of aggregated Huntingtin
A Iwata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease
M Valenza et al.
JOURNAL OF NEUROSCIENCE (2005)
Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons
JA Parker et al.
NATURE GENETICS (2005)
Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover
EG Lund et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila
BL Apostol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase
BJ North et al.
MOLECULAR CELL (2003)
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
JS Steffan et al.
NATURE (2001)
Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo
K Fassbender et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Neurological abnormalities in a knock-in mouse model of Huntington's disease
CH Lin et al.
HUMAN MOLECULAR GENETICS (2001)
Share Paper
